A phase I/II study of EG-70 (detalimogene voraplasmid) intravesical monotherapy for patients (pts) with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS)

被引：0
|
作者：
Palou, J. [1 ]
Marcq, G. [2 ]
Steinberg, G. [3 ]
Toscone, C. [4 ]
Sullivan, J. [4 ]
Linback, T. [4 ]
Pruthi, R. [4 ]
Bryce, R. [4 ]
Brown, G. [5 ]
机构：
[1] Fundacio Puigvert, Dept Urol, Barcelona, Spain
[2] CHU Lille, Urol, Ctr Hosp Reg Univ Lille, Lille, France
[3] Rush Univ, Urol, Coll Med, Chicago, IL USA
[4] EnGene Inc, Clin Dev, Waltham, MA USA
[5] Summit Hlth Jefferson Hlth New Jersey, Urol Dept, Voorhees, NJ USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.2109
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2023TiP
引用
收藏
页码：S1165 / S1165
页数：1
相关论文
共 50 条
  • [31] Phase II trial of BC-819 intravesical gene therapy in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC).
    Halachmi, Sarel
    Leibovitch, Ilan
    Zisman, Amnon
    Stein, Avi
    Benjamin, Shalva
    Sidi, Ami
    Knickerbocker, Ron
    Limor, Michal
    Moore, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [32] Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).
    Black, Peter C.
    Tangen, Catherine
    Singh, Parminder
    McConkey, David James
    Lucia, Scott
    Lowrance, William Thomas
    Koshkin, Vadim S.
    Stratton, Kelly Lynn
    Bivalacqua, Trinity
    Kassouf, Wassim
    Porten, Sima P.
    Bangs, Rick
    Plets, Melissa
    Lerner, Seth P.
    Thompson, Ian Murchie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).
    Black, Peter C.
    Catherine, Tangen
    Lerner, Seth P.
    McConkey, David James
    Lucia, M. Scott
    Woods, Michael
    Bivalacqua, Trinity
    Kassouf, Wassim
    Bangs, Richard Carlton
    Plets, Melissa
    Thompson, Ian Murchie
    Singh, Parminder
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] A phase II trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder
    DeCastro, G. J.
    Stein, M.
    Abate-Shen, C.
    Miles, C.
    Gray, J.
    Joffe, B.
    Anderson, C.
    Lenis, A.
    McKiernan, J. M. M.
    ANNALS OF ONCOLOGY, 2024, 35 : S1143 - S1143
  • [35] A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC).
    Woodcock, Victoria K.
    Purshouse, Karin
    Butcher, Chrissie
    Haddon, Caroline
    Verrall, Gillian
    Elhussein, Leena
    Salio, Mariolina
    Middleton, Mark R.
    Cerundolo, Vincenzo
    Crew, Jeremy
    Protheroe, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [36] Preliminary phase 2 clinical results of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients.
    Chamie, Karim
    Lee, John H.
    Rock, Amy
    Rhode, Peter R.
    Soon-Shiong, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] FINAL CLINICAL RESULTS OF PIVOTAL TRIAL OF IL-15RAFC SUPERAGONIST N-803 WITH BCG IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CIS AND PAPILLARY COHORTS
    Chang, Sam
    Chamie, Karim
    Hidalgo, Mark
    Kramolowsky, Eugene
    Sexton, Wade
    Reddy, Sandeep
    Soon-Shiong, Patrick
    JOURNAL OF UROLOGY, 2022, 207 (05): : E1047 - E1047
  • [38] OUTCOMES OF PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: A SINGLE-INSTITUTION, REAL-WORLD SERIES
    Cook, Grayden
    Howard, Jeffrey
    Margulis, Vitaly
    Lotan, Yair
    JOURNAL OF UROLOGY, 2021, 206 : E123 - E124
  • [39] Final results of CORE-001: A phase-2, single arm study of cretostimogene grenadenorepvec in combination with pembrolizumab in patients with BCG-unresponsive, non-muscle invasive bladder cancer with carcinoma in situ
    Li, Roger
    Shah, Paras H.
    Stewart, Tyler F.
    Bivalacqua, Trinity
    Lamm, Donald L.
    Geynisman, Daniel M.
    Meeks, Joshua J.
    Uchio, Edward M.
    Jacob, Joseph M.
    Dickstein, Rian J.
    Pearce, Shane
    Burke, James M.
    Steinberg, Gary D.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)
    Edward I. Broughton
    Kyna M. Gooden
    Katie L. Mycock
    Ivana Rajkovic
    Gavin Taylor-Stokes
    BMC Urology, 22
12345